Renal Dosing for Plaque Nail (Onychomycosis) Treatment
I was unable to locate specific renal dosing guidelines for "plaque nail" as a distinct medication entity in the provided evidence. However, if you are referring to onychomycosis (fungal nail infection) treatment in patients with renal impairment, the following evidence-based recommendations apply:
Systemic Antifungal Agents Requiring Renal Dose Adjustment
Terbinafine
Terbinafine is contraindicated in patients with hepatic impairment and requires caution in renal impairment. 1
- Standard dosing: 250 mg per day for 12-16 weeks for toenail infections 1
- Renal impairment consideration: The British Association of Dermatologists guidelines list renal impairment as a contraindication/caution but do not provide specific dose adjustments 1
- Monitoring: Baseline liver function tests and complete blood count are recommended 1
Fluconazole
Fluconazole requires dose adjustment in renal impairment and may serve as an alternative when terbinafine or itraconazole cannot be tolerated. 1
- Standard dosing: 150-450 mg per week for at least 6 months for toenail infections 1
- Renal impairment: Listed as a contraindication/caution requiring adjustment 1
- Monitoring: Perform baseline liver function tests and full blood count; monitor liver function in high-dose or prolonged therapy 1
Itraconazole
Itraconazole is first-line treatment for dermatophyte onychomycosis but requires monitoring in patients with hepatotoxicity risk. 1
- Standard dosing: 200 mg per day for 12 weeks continuously, or pulse therapy at 400 mg per day for 1 week per month (3 pulses for toenails) 1
- Renal considerations: While not specifically contraindicated in renal disease, hepatic function monitoring is essential 1
Griseofulvin
Griseofulvin is contraindicated in liver impairment and has lower efficacy compared to terbinafine and itraconazole. 1
- Standard dosing: 500-1000 mg per day for 12-18 months for toenail infection 1
- Renal considerations: No specific renal dose adjustment mentioned, but avoid in hepatic impairment 1
Topical Therapy (No Renal Adjustment Required)
Topical antifungals do not require renal dose adjustment and are useful alternatives when systemic therapy is contraindicated. 1
- Amorolfine 5% lacquer: Applied once or twice weekly for 6-12 months 1
- Ciclopirox 8% lacquer: Applied once daily for up to 48 weeks 1
- Tioconazole 28% solution: Applied twice daily for 6-12 months 1
General Principles for Renal Dosing
For medications requiring renal adjustment, reduce dosing frequency rather than dose amount for concentration-dependent drugs to maintain efficacy. 1, 2
- Maintain the milligram dose at 12-15 mg/kg per dose while extending the interval to two or three times weekly 1, 2
- Serum drug concentrations should be monitored to avoid toxicity in patients with severe renal impairment 1, 2
- Smaller doses may reduce drug efficacy, so maintaining dose amount while extending intervals is preferred 2
Clinical Approach
In patients with chronic kidney disease requiring onychomycosis treatment:
- Assess renal function using creatinine clearance or glomerular filtration rate 3
- Consider topical therapy first if systemic contraindications exist 1
- If systemic therapy needed: Choose fluconazole or itraconazole with appropriate monitoring, avoiding terbinafine if significant renal impairment present 1
- Monitor closely for drug accumulation and adverse effects 3
Important Caveats
- Drug dosing errors are common in patients with renal impairment and can cause adverse effects 3
- Chronic kidney disease affects drug absorption, distribution, metabolism, and clearance 3
- Nephrotoxic drugs should be avoided entirely in patients with renal impairment 1
- Baseline and regular monitoring of renal parameters are necessary when using potentially nephrotoxic medications 2